-
Thu24Jun2021
-
Tue06Jul2021Wed07Jul2021
-
Wed18Aug2021Sat21Aug2021
-
Sat25Sep2021Tue28Sep2021
-
Tue28Sep2021Wed29Sep2021Rotterdam, The Netherlands and online
-
Mon04Oct2021Thu07Oct2021
-
Tue05Oct2021Thu07Oct2021Live and virtual
-
Thu21Oct2021Sat23Oct2021
Latest News
Sectoral Asset Management makes US$9 million investment into Cagent Vascular
Cagent Vascular recently announced the investment of US$9 million by Sectoral Asset Management. Along with the investment, Marc-Andre Marcotte has joined the board of...
Features
Vascular News’ top 10 most popular stories of May 2021
Expanding eligibility for endovascular aneurysm repair (EVAR), new tools for chronic limb-threatening ischaemia (CLTI), and promising data for arteriovenous (AV) fistula remote monitoring all...
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Videos
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial, the results of which he presented at the American College of Cardiology’s 70th Annual Scientific Session (ACC.21, 15–17 May, virtual) and which highlighted a reduced risk of...
